Authors: Rajiv Marwah & Ritesh Kumar: 2022 was the year of generative artificial intelligence. OpenAI blew our minds from DALL-E2 to ChatGPT now. ChatGPT can generate intelligent responses to natural language inputs. It’s stunning! It can answer general questions, code, write stories and poems, suggest itineraries, etc….
The more I study the world of clinical trials and read the comments of the brightest minds who comment on them, the more I notice the absence of agreement on two important subjects. These subjects are “patient engagement” and “patient…
Authors: Rajiv Marwah & Ritesh Kumar: In a rather animated conversation with a peer of mine, I was told that “Chatbots or Virtual Assistants have no role to play in improving Clinical Trial patient recruitment or patient retention”. For instance,…
I am all for changes in paradigm, as they are frequently for the best. But perhaps we’ve finally gone too far, and even “jumped the rails”. Depending on your perspective, we are currently either in the middle of positive change,…
Birth of a New Entity — The IRO or Independent Research Organization (Sometimes called the Innovative Research Organization) Clinical trials have been progressing quickly and rather quietly as they have moved rapidly beyond the boundaries of the time-honored model for…
While the pandemic has necessitated an acceleration for non-Covid clinical trials (reduced by almost 57% during 2020-21), it has also meant that Sponsors/ Institutions must find an innovative, yet compliant, way of running them. Moreover, the number of complex trials…
As a clinician and a trials investigator, I’ve made several limited observations that are both encouraging and concerning, all at the same time. I have had the growing sense that many of the existing workflows required for clinical trials are,…